We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Scholar Rock Holding Corp
2 own
6 watching
Current Price
$0
$0.25
(2.02%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
639.04M
52-Week High
21.17
52-Week Low
4.325
Average Volume
0.05M
Dividend Yield
--
P/E Ratio
--
Market Capitalization639.04M52-Week High21.1752-Week Low4.325Average Volume0.05MDividend Yield--P/E Ratio--What does the Scholar Rock Holding Corp do?
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Scholar Rock Holding Corp make?
News & Events about Scholar Rock Holding Corp.
Ticker Report
23days ago
Scholar Rock Holding Co. (NASDAQ:SRRK Get Rating) major shareholder Public Equities L.P. Invus bought 48,774 shares of the companys stock in a transaction that occurred on Thursday, January 5th. The shares were bought at an average cost of $9.33 per share, for a total transaction of $...
Zolmax
23days ago
Scholar Rock Holding Co. (NASDAQ:SRRK Get Rating) major shareholder Public Equities L.P. Invus bought 48,774 shares of the companys stock in a transaction that occurred on Thursday, January 5th. The shares were bought at an average cost of $9.33 per share, for a total transaction of $455,061.42. ...
Business Wire
1month ago
Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will present at the J.P. Morgan 41st Annual Healthcare Conference on Tuesday, January...
Business Wire
2 months ago
Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced early data from its Phase 1 DRAGON proof-of-concept trial of SRK-181, a selective inhibitor of...
Business Wire
2 months ago
Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the appointment of Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer. Dr. Marantz is an...
Frequently Asked Questions
Frequently Asked Questions
What is Scholar Rock Holding Corp share price today?
Can Indians buy Scholar Rock Holding Corp shares?
How can I buy Scholar Rock Holding Corp shares from India?
Can Fractional shares of Scholar Rock Holding Corp be purchased?
What are the documents required to start investing in Scholar Rock Holding Corp stocks?
What is today’s traded volume of Scholar Rock Holding Corp?
What is today’s market capitalisation of Scholar Rock Holding Corp?
What is the 52-Week High and Low Range of Scholar Rock Holding Corp?
What percentage is Scholar Rock Holding Corp down from its 52-Week High?
What percentage is Scholar Rock Holding Corp up from its 52-Week Low?
Current Price
$0
$0.25
(2.02%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.